High-dose rituximab, plasma exchange with treated pooled human plasma, and aggressive monitoring of isoagglutinins in ABO incompatible kidney transplantation: 2-year results of a prospective trial / E. Favi, R. Cacciola, M. Ferraresso, C. Puliatti. - In: TRANSPLANT INTERNATIONAL. - ISSN 0934-0874. - 30:Suppl. 2(2017 Sep), pp. 475-475. ((Intervento presentato al 18. convegno European Society for Organ Transplantation tenutosi a Barcelona nel 2017.
High-dose rituximab, plasma exchange with treated pooled human plasma, and aggressive monitoring of isoagglutinins in ABO incompatible kidney transplantation: 2-year results of a prospective trial
E. Favi;M. Ferraresso;
2017
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
tri.13053.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
6.09 MB
Formato
Adobe PDF
|
6.09 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
